Long-term tolerability and efficacy of lamotrigine in pediatic patients with epilepsy

Journal of Child Neurology

Volumn 17, Issue 4, 2002, Pages 278-285

  Duchowny, Michael ^a,c   Gilman, Jamie ^a   Messenheimer, John ^b   Womble, Gilda ^b   Risner, Marcus ^b   Ayala, R ^c   Konkol, R ^c   Campbell, R ^c   Crumrine, P K ^c   Cruse, R P ^c   Delgado, M ^c   Fountain, N ^c   Enlow, T ^c   Fakhoury, T A ^c   Casadonte, J ^c   Frank, L M ^c   Graf, W ^c   Griebel, M L ^c   Griesemer, D A ^c   Wannamaker, B ^c   Olson, D M ^c   Silverstein, F ^c   Hurst, D ^c   Jackson, A ^c   Laxer, K D ^c   Bluestone, D ^c   Maria, B ^c   Lassiter, A ^c   Levisohn, P M ^c   Libenson, M ^c   Mitchell, W ^c   Montouris, G ^c   Murphy, J ^c   Oommen, K J ^c   Park, Y D ^c   Parks, B R ^c   Snodgrass, S ^c   Pellock, J M ^c   Ramsay, E ^c   Ritter, F J ^c   Schimschock, J R ^c   Khan, A ^c   Shuman, R ^c   Tennison, M ^c   Cheng, R D ^c   Turk, W ^c   Wise, M S ^c   Bebin, E ^c   Gonzalez, A ^c   Ruiz, M ^c   Gonzalez, R C ^c   Llamosa, G ^c   Saiers, Jane ^c   more..

^a MIAMI CHILDREN'S HOSPITAL   (United States)

^b GLAXOSMITHKLINE   (United States)

^c NONE   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; LAMOTRIGINE; TRIAZINE DERIVATIVE; PLACEBO;

ADOLESCENT; ARTICLE; CHILD; CLINICAL TRIAL; EPILEPSY; FEMALE; HUMAN; INFANT; MALE; MULTICENTER STUDY; PRESCHOOL CHILD; TIME; TREATMENT OUTCOME; ABSENCE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DATA ANALYSIS; DISEASE CONTROL; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG TOLERABILITY; DRUG USE; FOCAL EPILEPSY; HEADACHE; INFECTION; LENNOX GASTAUT SYNDROME; LONG TERM CARE; MAJOR CLINICAL STUDY; MONOTHERAPY; NAUSEA AND VOMITING; PNEUMONIA; PRIORITY JOURNAL; SHORT COURSE THERAPY; SOMNOLENCE; VERTIGO;

ADOLESCENT; ANTICONVULSANTS; CHILD; CHILD, PRESCHOOL; EPILEPSY; FEMALE; HUMANS; INFANT; MALE; TIME FACTORS; TREATMENT OUTCOME; TRIAZINES; HUMAN; SUPPORT, NON-U.S. GOV'T;

EID: 0035987240     PISSN: 08830738     EISSN: None     Source Type: Journal    
DOI: 10.1177/088307380201700408     Document Type: Article

References (32)

1. Seizures and epilepsy
2. The neurobiology and consequences of epilepsy in the developing brain
3. Quality of life of people with epilepsy: A European study
4. A placebo-controlled trial of lamotrigine add-on therapy for partial seizures in children
5. Lamictal monotherapy for typical absence seizures in children
6. Lamotrigine for generalized seizures associated with the Lennox-Gastaut syndrome
7. Lamotrigine for the treatment of epilepsy in childhood
8. Lamotrigine in treatment of 120 children with epilepsy
9. Intractable epilepsy in children. The efficacy of lamotrigine treatment, including non-seizure-related benefits
10. Lamotrigine in resistant childhood epilepsy
11. Three-year efficacy and tolerability of add-on lamotrigine in treatment-resistant epileptic children
12. Prospective, open-label, add-on study of lamotrigine in 56 children with intractable generalized epilepsy
13. Lamotrigine treatment in childhood drug-resistant epilepsy
14. The efficacy of lamotrigine in children and adolescents with refractory generalized epilepsy: A randomized, double-blind, crossover study
15. Lamotrigine as an add-on drug in the management of Lennox-Gastaut syndrome
16. The use of lamotrigine in juvenile myoclonic epilepsy
17. Lamotrigine in infantile spasms
18. Lamotrigine in Rett syndrome
19. Lamotrigine in Rett syndrome: Treatment experience from a pilot study
20. Lamotrigine monotherapy in children
21. Double-blind comparison of lamotrigine and carbamazepine in newly diagnosed epilepsy
22. Lamotrigine monotherapy in newly diagnosed untreated epilepsy: A double-blind comparison with phenytoin
23. Safety review of adult clinical trial experience with lamotrigine
24. Differential cognitive and behavioral effects of carbamazepine and lamotrigine
25. Risk of serious cutaneous disorders after initiation of use of phenytoin, carbamazepine, or sodium valproate: A record linkage study
26. Epilepsy
27. The tolerability of lamotrigine in children
28. Validation of a population pharmacokinetic model for adjunctive lamotrigine therapy in children
29. Long-term safety and efficacy of lamotrigine in paediatric patients with epilepsy
30. Rash in adult and pediatric patients treated with lamotrigine
31. Lamotrigine